Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis
Chen, Ming and Zhang, Jiangwen and Berger, Alice H. and Diolombi, Moussa S. and Ng, Christopher and Fung, Jacqueline and Bronson, Roderick T. and Castillo-Martin, Mireia and Thin, Tin Htwe and Cordon-Cardo, Carlos and Plevin, Robin and Pandolfi, Pier Paolo (2018) Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis. Journal of Clinical Investigation, 129 (1). pp. 215-222. ISSN 0021-9738 (https://doi.org/10.1172/JCI99699)
Preview |
Text.
Filename: Chen_etal_JCI_2018_Compound_haploinsufficiency_of_Dok2_and_Dusp4_promotes.pdf
Final Published Version Download (9MB)| Preview |
Abstract
Recurrent broad-scale heterozygous deletions are frequently observed in human cancer. Here we tested the hypothesis that compound haploinsufficiency of neighboring genes at chromosome 8p promotes tumorigenesis. By targeting the mouse orthologs of human DOK2 and DUSP4 genes, which were co-deleted in approximately half of human lung adenocarcinomas, we found that compound-heterozygous deletion of Dok2 and Dusp4 in mice resulted in lung tumorigenesis with short latency and high incidence, and that their co-deletion synergistically activated MAPK signaling and promoted cell proliferation. Conversely, restoration of DOK2 and DUSP4 in lung cancer cells suppressed MAPK activation and cell proliferation. Importantly, in contrast to downregulation of DOK2 or DUSP4 alone, concomitant downregulation of DOK2 and DUSP4 was associated with poor survival in human lung adenocarcinoma. Therefore, our findings lend in vivo experimental support to the notion that compound haploinsufficiency, due to broad-scale chromosome deletions, constitutes a driving force in tumorigenesis.
ORCID iDs
Chen, Ming, Zhang, Jiangwen, Berger, Alice H., Diolombi, Moussa S., Ng, Christopher, Fung, Jacqueline, Bronson, Roderick T., Castillo-Martin, Mireia, Thin, Tin Htwe, Cordon-Cardo, Carlos, Plevin, Robin ORCID: https://orcid.org/0000-0002-7849-1220 and Pandolfi, Pier Paolo;-
-
Item type: Article ID code: 66332 Dates: DateEvent26 November 2018Published26 November 2018Published Online9 October 2018AcceptedSubjects: Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
Medicine > Pharmacy and materia medicaDepartment: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 11 Dec 2018 12:37 Last modified: 12 Dec 2024 07:26 URI: https://strathprints.strath.ac.uk/id/eprint/66332